Frontiers Announces New External Advisory Committee Members
August 13, 2020
Frontiers: University of Kansas Clinical and Translational Science Institute, is pleased to announce the appointment of four new members of the Frontiers External Advisory Committee (EAC). Joining the EAC are: Molly Carnes, MD, MS (University of Wisconsin-Madison); Will Dere, MD, FACP (University of Utah Health Sciences Center); Julianne Imperato-McGinley, MD (Weill Cornell Medical College); and Jay F. Piccirillo, MD (Washington University in St. Louis ).
The Frontiers EAC, which is comprised of clinical and translational science experts from across the CTSA Consortium, provides advice on the direction of Frontiers, addresses issues of concern and suggests strategies to assist Frontiers in accomplishing its vision and objectives.
"We are excited to welcome Drs. Carnes, Dere, Imperato-McGinley and Piccirillo to the External Advisory Committee. Together, they bring decades of leadership in key areas," said Mario Castro, MD, MPH, Frontiers Director and Chief of Pulmonary, Critical Care and Sleep Medicine at University of Kansas Medical Center. "Their counsel and expertise will help guide and strengthen our efforts to advance scientific discovery and translational research, particularly as we prepare and submit our Clinical and Translational Science Award renewal application next year."
These new appointees will join continuing EAC members Lucila Ohno-Machado, MD, PhD (University of California San Diego) and Consuelo H. Wilkins, MD, MSCI (Vanderbilt University) and bring the total EAC membership to six.
About the new Frontiers EAC members
Molly Carnes, MD, MS, is the Virginia Valian Professor of Medicine, Psychiatry and Industrial and Systems Engineering at the University of Wisconsin-Madison where she directs the Center for Women's Health Research in the School of Medicine and Public Health and co-directs the Women in Science and Engineering Leadership Institute in the College of Engineering. Dr. Carnes has published over 165 papers, served two terms on NIH Advisory Councils, and received awards for her research including the 2019 Bernadine Healy Award for Visionary Leadership in Women's Health.
Will Dere, MD, FACP, is Professor of Endocrinology and Metabolism at the University of Utah Health Sciences Center where he also serves as Associate Vice President for Research; Co-director of the Utah Center for Clinical and Translational Science; and Co-Director of the Center for Genomic. Additionally, he is the T. Lue and Hope Bettilyon Presidential Endowed Chair of Internal Medicine for Diabetes Research. Dr. Dere has extensive experience in clinical research through his 25-year stint in the biopharmaceutical industry.
Julianne Imperato-McGinley, MD, is the Abby Rockefeller Mauzé Distinguished Professor of Medicine in Endocrinology and Associate Dean for Translational Research and Educational Training; Director and Principal Investigator of the Clinical and Translational Science Center and Chief of the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medical College. A clinical and translational researcher with over 30 years of NIH funding, Dr. Imperato-McGinley published her landmark paper in Science in 1974.
Jay F. Piccirillo, MD, is a Professor of Otolaryngology, Medicine, Biostatistics, and Occupational Therapy and Vice Chair for Research and Director of the Clinical Outcomes Research Office for the Department of Otolaryngology - Head & Neck at Washington University in St. Louis School of Medicine. He also directs the National Institute on Deafness and Other Communication Disorders-supported T32 Physician Scholars Training Program and the National Center for Advancing Translational Sciences-supported TL1 Predoctoral Interdisciplinary Clinical Research Training Program.
Sep 10, 2020